• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Basic Materials·600257.SS
Share

Dahu Health Industry Co., Ltd. Stocks

CN¥ 5.47Last Updated 26.05.2026

Issuer Rating

4/7
Performance

Modest

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 393.71M

CN¥ 5.47
Key Takeaways

Risk factor

Meaningful price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Dahu Aquaculture Co.,Ltd., together with its subsidiaries, provides freshwater fishes in China. The company offers freshwater organic and glacial fish, Dahu organic turtles, and Jiangsu Yangcheng Lake hairy crabs; Xiangyunyu and Deshan wines; and other consumer products. It is also involved in water environment management activities; and developing and producing aquatic fingerlings. In addition, the company offers health food and health care products; cosmetics products; and pearl jewelry and ornaments. Further, it engages in industrial chain finance, pharmaceutical trade, and food processing businesses. Dahu Aquaculture Co.,Ltd. was founded in 1999 and is based in Changde, China.

Company Valuation

Slightly overvalued
3/7

Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITDA, re

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

28.05.2026 20:33

JPMorgan finds new positive factor for US stocks growth

28.05.2026 19:22

'It's crazy': chipmaker stocks break dot-com era records. Will the rally continue?

28.05.2026 18:56

US stocks retreated from highs amid accelerating inflation and escalating war

28.05.2026 17:55

Consumer spending inflation in the US has reached a three-year high

28.05.2026 17:21

The Russian ruble has strengthened to a three-year high. What is helping it?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026